| Symbol | WUHN |
|---|---|
| Name | WUHAN GENERAL GROUP (CHINA), INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 7925 South Africa Unit 1, Masons Press 7 Ravenscraig Road |
| Telephone | +27 82 413 5457 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | US |
| Incorporated On | 2006 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | UNAUDITED |
| Reporting Status | Dark: Alternative Reporting Standard |
| CIK | 0000842694 |
| Description | Wuhan General Group, Inc. (DBA M2bio Sciences) , is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research and emerging technologies. Additional info from OTC: |
Expert Market symbol attribute type Security_Name was changed. Previous value: -. New value: WUHAN GENERAL GROUP INC.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: WUHAN GENERAL GROUP INC.
Read more